Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension is a research paper published in Biochemical Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NHLBI
Grant: 5R01HL114977
NHLBI NIH HHS
Grant: R01 HL114977
NHLBI NIH HHS
Grant: R01 HL060061
Lilly Endowment
National Institutes of Health
FWCI
1.90
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals